Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Technologist files class action lawsuit claiming imaging provider violated labor laws

Attorneys accuse Digirad of failing to pay minimum wages or overtime and shirking laws requiring regular meal and rest periods. 

Thumbnail

Physicians urge HHS to tap emergency funds to help practices survive Change Healthcare cyberattack

“There’s a lot of scrambling among our members,” Radiology Business Management Association Executive Director Bob Still said Monday. 

legal liability malpractice artificial intelligence

AI in healthcare: 3 areas of likely risk for legal liability

As healthcare AI opens new avenues to improve care quality without unduly increasing operational costs, the technology also expands potential exposure to civil and criminal liabilities. And that’s not only for providers but also payers and suppliers.

workplace violence in hospitals

What is your state doing to protect healthcare workers who are potentially in harm’s way every day?

In the absence of federal laws to address violence against healthcare workers, most state legislatures have taken up the cause on their own.

Kate Hanneman, MD, University Of Toronto, explains why vendors and hospitals are increasingly discussing lowing their carbon footprint by starting with radiology. 

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Thumbnail

SimonMed imaging centers avoided regulation, even after safety concerns

The chain of imaging centers was given a private practice exemption in Arizona, but it includes more than 60 different facilities.

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Agent Drug-Coated Balloon (DCB) for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease.

FDA approves Boston Scientific’s new drug-coated balloon for coronary in-stent restenosis

Interventional cardiologists have been anticipating this news for quite some time. The device, the first of its kind, provides an alternative treatment option to repeat PCI or cardiac surgery for patients with coronary ISR.

Department of Justice DOJ

DOJ collects $1.9B from healthcare in 2023, with imaging provider making 1 of the biggest payouts

Cardiac Imaging Inc. agreed to pay $85 million in October, the largest judgment in the “Laboratory, Pathology, Radiology and Diagnostics" category.